The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) central nervous system (CNS) metastases (mets).
Carey K. Anders
Consultant or Advisory Role - BiPar Sciences (U); Merrimack (U); Sanofi (U); to-BBB technologies BV (U)
Research Funding - BiPar Sciences; Bristol-Myers Squibb; Geron; Novartis; Sanofi
Allison Mary Deal
No relevant relationships to disclose
Vandana Gupta Abramson
No relevant relationships to disclose
Minetta C. Liu
Honoraria - BiPar Sciences
Research Funding - BiPar Sciences
Anna Maria Storniolo
No relevant relationships to disclose
John T. Carpenter
No relevant relationships to disclose
Shannon Puhalla
No relevant relationships to disclose
Rita Nanda
No relevant relationships to disclose
Amal Melhem-Bertrandt
No relevant relationships to disclose
Nancy U. Lin
Research Funding - Genentech; Geron
Paul K. Marcom
No relevant relationships to disclose
Catherine H. Van Poznak
Employment or Leadership Position - Bone and Cancer Foundation; Paget Foundation
Research Funding - NIH - NIDCR; Translational Breast Cancer Research Consortium
Other Remuneration - NCCN (Educational Presentation Development); School of Breast Oncology (Educational Presentation Development); UpToDate (Intellectual Property Interests); Western Michigan University School of Medicine (Educational Presentation Development)
Vered Stearns
Research Funding - Abbott Laboratories; Abraxis BioScience; Merck; Novartis; Pfizer
Michelle E. Melisko
No relevant relationships to disclose
J. Keith Smith
No relevant relationships to disclose
Olga Karginova
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose
Charles M. Perou
Employment or Leadership Position - Bioclassifier (U); University Genomics (U)
Stock Ownership - Bioclassifier; University Genomics
Antonio C. Wolff
No relevant relationships to disclose
Lisa A. Carey
No relevant relationships to disclose